Patent · US Active

Gene therapy methods

US9783822B2 · kind B2 · utility

1Cited by
20References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 23, 2011
Grant dateOct 10, 2017
Priority date
Expiry dateFeb 24, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2830/40
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention generally provides improved gene therapy vectors, cell-based compositions, and methods of using the same in methods of gene therapy. The present invention further provides improved gene therapy compositions for expanding hematopoietic cells and related methods for treatment of diseases, disorders, and conditions of the hematopoietic system such as thalassemias and anemias.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.